Your browser doesn't support javascript.
loading
Study design considerations to assess the impact of potential drug-drug interactions in first-in-human studies in oncology drug development.
Subramaniam, Sriram; Shord, Stacy S; Leong, Ruby; Norsworthy, Kelly; Rahman, Atiqur; Booth, Brian; Okusanya, Olanrewaju.
Afiliação
  • Subramaniam S; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Shord SS; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Leong R; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Norsworthy K; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Rahman A; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Booth B; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Okusanya O; US Food and Drug Administration, Silver Spring, Maryland, USA.
Clin Transl Sci ; 16(5): 719-722, 2023 05.
Article em En | MEDLINE | ID: mdl-36823411
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article